強
強気
強気 · 25%OSCR
$20.09
シナリオ価格
$31.890
-1.505 (-4.72%)終値時点
Loading chart…
- 高値
- 33.505
- 始値
- 33.380
- 出来高加重平均価格
- 32.35
- 出来高
- 5.75M
- 時価総額
- 4.19B
- 安値
- 31.650
- 売買代金
- 186.16M
- EV/EBITDA（TTM）
- 4.13
Oscar Health, Inc. is a healthcare technology company built around a full-stack technology platform. The Company serves individuals, families, and employees through the Patient Protection and Affordable Care Act (ACA). It also offers health technology solutions that power the healthcare industry through +Oscar. It also wholly owns three businesses operating in the individual market: Lucie, Inc., a technology enrollment platform for consumers, employers and brokers; Trove Group Inc., an insurance agency that sells individual medical and supplemental health products, and HealthInsurance.org, LLC, a lead generation website providing educational content to help consumers navigate health insurance as well as the ACA and Medicare marketplaces.
AI分析 of Oscar Health Inc (OSCR)
買いOscar Health Inc is a good buy right now due to its current price of $33.37, which is significantly below the analyst price target of $42 from Raymond James, indicating a potential upside of 25.5%. Additionally, the company has shown strong earnings growth with a reported EPS of 1.10, a 155.81% surprise over estimates, and a robust year-to-date change of +122.91%. However, the main risk is the forward P/E ratio of 588.24, which suggests that the stock may be overvalued if growth expectations are not met.
バリュエーション指標
Oscar Health Inc（OSCR）の現在の予想PERは588.24で、5年平均は123.87です。
Alphio AI による OSCR の価格シナリオ
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト（25 / 50 / 25）であり、保証ではありません。
OSCR を保有するクジラ
イベントタイムライン
ニュース
9.510-12NewsfilterOscar Health to Release Q3 2026 Financial Results on November 5
2.009-30FoolInvestors Overlook Healthcare Sector Amid AI Focus
5.009-25FoolFour Overlooked Stocks with Doubling Potential
- 8.509-19Newsfilter
Oscar Health Share Distribution of 6.3 Million Shares by Thrive Capital
2.009-12Yahoo FinanceHealthcare Stocks Surge Amid Macroeconomic Uncertainty
OSCR のよくある質問 — Alphio AI が回答
Oscar Health, Inc. is a healthcare technology company built around a full-stack technology platform. The Company serves individuals, families, and employees through the Patient Protection and Affordable Care Act (ACA). It also offers health technology solutions that power the healthcare industry through +Oscar. It also wholly owns three businesses operating in the individual market: Lucie, Inc., a technology enrollment platform for consumers, employers and brokers; Trove Group Inc., an insurance agency that sells individual medical and supplemental health products, and HealthInsurance.org, LLC, a lead generation website providing educational content to help consumers navigate health insurance as well as the ACA and Medicare marketplaces. It operates in the Financials sector (HOSPITAL & MEDICAL SERVICE PLANS industry).
Oscar Health Inc is a good buy right now due to its current price of $33.37, which is significantly below the analyst price target of $42 from Raymond James, indicating a potential upside of 25.5%. Additionally, the company has shown strong earnings growth with a reported EPS of 1.10, a 155.81% surprise over estimates, and a robust year-to-date change of +122.91%. However, the main risk is the forward P/E ratio of 588.24, which suggests that the stock may be overvalued if growth expectations are not met.
コミュニティ
もっと見る ↗
$oscr is finishing up a 5 year IPO base. In 2021 they did $1.84B in revenue. This year they will do 10X. You missed nothing. This is the beginning
もっと見る
$OSCR CMS has cracked down on unauthorized enrollments after tracking a surge in consumer complaints, analyzing statistically implausible application rates submitted by specific brokers, and reviewing accounts missing critical identifying information like Social Security numbers. They have canceled approximately 315,000 unauthorized enrollments covering more than 760,000 individuals, which is expected to result in a return of roughly $2.2B in taxpayer-funded subsidies. Oscar Health accounted for >250,000 of these enrollments!
もっと見る
$OSCR Management grew and sold Aethna to CVS and shareholders did great. Can there be a repeat? Sometimes they rhyme. If there is a solution for healthcare, OSCR might have the answers. Look at the base since the IPO. You haven't missed a thing. We might be at the point where the meat of the move begins ahead.
もっと見る
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。